Showing posts with label plastic surgery. Show all posts
Showing posts with label plastic surgery. Show all posts

Monday, September 26, 2011

Alexis Hauk: Surgical trend a step in wrong direction for women

Wednesday, May 28, 2008

Adhesion Headlines ARDvark Blog

Health Care Coalition Pushes For E-Prescribing Legislation, Citing Existing Standards For ImplementationThe technical standards necessary to establish a national electronic prescribing system already have been adopted by physicians and pharmacy software companies, according to a letter to lawmakers from a coalition of health...[read article]

Op-Eds Address Presidential Candidates' Health Care Proposals

Antibiotics Accompanying Surgery Prevent Some Infections But Increasingly Cause Another

Abbott Presents Long-term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA® (adalimumab) Maintained Remission

AMITIZA(R) (lubiprostone) 8 Mcg Now Available To Treat Irritable Bowel Syndrome With Constipation In Adult Women

Senate Passes War Funding Package, Including Provisions On Medicaid, Birth Control Discounts

Ovarian Cancer Vaccine Clinical Trial Begins At Cancer Treatment Centers Of America

Fibroids Common, But Women Have Options

Kroger Matches Discounts Of Other Retailers On Prescription Women's Health Medications

C-Sections A Critical Factor In Preterm Birth Increase

Is Fertility Affected By Chemicals In The Environment?

Fertility Warning To Female Veterinarians

NovaBay (NBY) Announces Positive Results From Phase IIA Study Of AgaNase(TM) For Nasal Decolonization Of Staph Including MRSA

Risks For Painkiller Abuse Do Not Outweigh Benefits In Chronic Pain

Structure Of Receptor For Hot Chili Pepper And Pain Revealed

Untreated Depressed People Have Fewer Serotonin & Opioid Receptors, And Variation Is Linked To Symptoms And Treatment Response

New Study Suggests Tapentadol IR For Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared To Oxycodone IR

Infections/Inflammation Of The Genitourinary Tract: Interstitial Cystitis

The Effect Of Urologic Disorders And Treatments On Fertility

Tuesday, March 25, 2008

Adhesions News ARDvark Blog

Surgeons Use Transplant Surgery To Remove Tumour
Written by Catharine Paddock, PhD
In a 15-hour operation, surgeons in the US used transplant surgery to remove and replace multiple abdominal organs so they could reach and cut out a tumour in a female patient who had a rare form of cancer...[read article]
Fertility Treatments And The Surprising Power Of The Pill

Free Drug Samples May Burden Patients' Pockets

FDA Classifies Medtronic's Physician Communication Related To Inflammatory Mass Formation From Intrathecal Drug Therapy

CHMP Upholds Negative Opinion For The EU Application For Cimzia(R) In The Treatment Of Crohn's Disease

Massachusetts Health Insurance Connector Approves 10% Premium Increases; State Finance Officer Says Program Is Underfunded

EndoGastric Solutions(TM) Announces Results Of EsophyX(TM) Multi-Center GERD Study

New Hope Available For The Millions Suffering From Chronic Fatigue Syndrome And Fibromyalgia

Time To Initiation Of Pentosan Polysulfate Sodium Treatment After Interstitial Cystitis Diagnosis: Effect On Symptom Improvement

Beyond The Abstract - Insight Into Urogynecologic Features Of Women With Interstitial Cystitis/Painful Bladder Syndrome

Can Psychotherapy Reverse Chronic Post-Traumatic Stress Disorder?

New York Times Examines 'Migration' Of Top Medical Students To Dermatology, Plastic Surgery

StatMedica Defends Medical Tourism

ASA Commemorates Doctors Day 2008

SUFU 2008 Winter Meeting - Genetic Factors In SUI/Pelvic Organ Prolapse

NovaBay Pharmaceuticals Commences Phase I Human Clinical Trial For The Prevention Of Catheter Associated Urinary Tract Infections

Thursday, January 31, 2008

Surgical Scarring Reduced By Biodegradable Film

Time For A Check Up...Of Your Insurance Coverage

Tranzyme Pharma Receives IND Clearance For Its Oral Ghrelin Agonist, TZP-102, For The Treatment Of Gastroparesis

Fatal Infections In Critically Ill Patients May Be Caused By Cosmetic Products

New Class Of Highly Selective 5-HT4 Receptor Agonists Provides The Next Generation Of GI Treatments

Fatalistic Beliefs And Unethical Behavior

The World's First 'Operation' Gown

Overrule Your Budget Office, Mr. President - By Newt Gingrich And David Merritt, USA

CSCI Report Shows Glaring Inconsistencies In Care And Support For Vulnerable Adults That Must Be Addressed, Says King's Fund, UK

Gastric Surgery Link To Diabetes Treatment, UK

Radius Announces Launch Of RAD1901 Clinical Program For The Treatment Of Hot Flashes

Study Analyzes Best Approach For Treating Abdominal Aortic Aneurysms

Study Showing Differences In Access To Pain Treatment Illustrates Overall Issue Of Health Disparities, Opinion Piece Says

Tiller Attorneys Ask Kan. Court To Block Subpoenas For Records Of 2,000 Women Who Sought Abortions

A Concept For Cost-Benefit Assessment Methods In The German Health Care System

Research Into Inflamation, Sensory Neurons And Low Back Pain Receives $1.7 Million

BioLineRx Presents Pre-Clinical Data Demonstrating That BL-1021 Is Safe And Effective In Treating Neuropathic Pain

Tips For Dry Winter Skin, From The Harvard Health Letter

Antidepressants Unproven As Treatment For Low Back Pain

Tuesday, January 29, 2008

Adehsions medical Headlines ARDvark Blog

Increase In Contraceptive Costs At Colleges Reaching Crisis Level, Advocates Say

CMS Proposes Stronger Protections For Beneficiaries Using Durable Medical Equipment, Prosthetics, Orthotics, And Supplies, USA

Autoimmunity Center To Be Established At University Of Colorado Denver

New Center For Reproduction And Infertility Research At Illinois Funded By National Institutes Of Health

RNs Praise Courageous Vote By Senate Committee On Badly Flawed Healthcare Bill, USA

Improved Understanding Of Pain With The Help Of The Naked Mole-Rat

Survey Reveals Surgical Patients Enter Theatre Cold; May Be At Increased Risk Of Wound Infection And Longer Hospital Stays, UK

Studies Demonstrate Increased Efficacy Of Erbitux In Metastatic Colorectal Cancer Patients With KRAS Wild-type Tumors

Massachusetts Governor Proposes $28.2B Budget, Including $400M Increase In Spending For State's Health Insurance Law

Medi-Cal Cuts Will Exacerbate Health Care Crisis In California Health Care Providers Will Testify, USA

Medisyn Technologies Awarded Phase I SBIR Grant By Department Of Defense To Discover And Develop Novel NSAIDs With Reduced GI Toxicity

Patients Encouraged To See A Physician If They Experience Symptoms Suggestive Of GERD

Patent Issued For Barr's Extended-Cycle Contraceptive Seasonique

GlaxoSmithKline And Adolor Report Favourable FDA Advisory Committee Meeting For Entereg® For The Management Of Postoperative Ileus In Bowel Resect

Thursday, January 24, 2008

Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO

Proceeds to assist with expansion of Ascension's product line and distribution network

AUSTIN, Texas, Jan. 21 /PRNewswire/ -- Ascension Orthopedics, Inc., an emerging medical device company that develops, manufactures and markets joint replacement, trauma and tissue regeneration surgical implants for use in upper and lower extremities, announced today that it has secured $21 million in a Series D financing. This new round of funding will be used primarily to expand the current product line and enhance the Company's product marketing and distribution network.
Leading this Series D financing as the majority investor is Frazier Healthcare Ventures, one of the nation's leading providers of venture and growth equity capital to emerging healthcare companies. Alan Frazier, General Partner and Founder of Frazier Healthcare Ventures will join Trevor Moody, General Partner of Frazier Healthcare, and Steven Tallman, Venture Partner of Frazier Healthcare on Ascension's Board of Directors.
"We feel that Ascension is uniquely positioned to experience substantial revenue growth with the expansion of its distribution network and product line and are pleased to have the opportunity to be a part of this growth development," comments Trevor Moody, General Partner of Frazier Healthcare.
In addition to this financing, Ascension Orthopedics is pleased to announce that Mr. Andrew J. Miclot will join the company as CEO. Mr. Miclot brings more than 25 years of experience in executive management and marketing within the orthopedic industry. He was most recently Global Senior Vice President of Marketing Orthopedics at Orthofix. Prior to this, he held senior positions at leading medical device companies including Symmetry Medical, DePuy and Zimmer. During his 13 years at Symmetry Medical, where he held a variety of senior positions including Senior Vice President and Investor Relations Officer, Andy played a meaningful role in growing Symmetry's annual revenues from approximately $10MM to over $260MM. "I am very excited to have joined Ascension Orthopedics and to have the opportunity to work with the existing management team and board of directors. Ascension is uniquely positioned for significant growth in the orthopedics extremities marketplace," said Mr. Miclot.
"I am extremely pleased Frazier Healthcare Ventures has the confidence in Ascension to provide this important round of equity financing that will enable us to expand further on the key cornerstones of our business -- product innovation and marketing," said Jerome Klawitter, PhD. Founder, Chief Scientific Officer and former CEO. "I look forward to turning over my CEO duties to Mr. Miclot and working with him to leverage our respective backgrounds in product innovation and product marketing."
About Ascension Orthopedics, Inc.
Ascension Orthopedics began product development in Austin, Texas in 1996 and in 2001 received FDA PMA approval for its first product, an innovative pyrolytic carbon total joint replacement for the MCP (Knuckle) joint of the hand. The company has since increased its joint replacement product line to include implants for the shoulder, elbow, wrist, fingers and toes. In addition to joint replacements, Ascension Orthopedics offers trauma products to treat bone fractures occurring in the hand and arm as well as the foot and ankle. Ascension also markets tissue regeneration products for the upper and lower extremities, including implants that help reconnect severed nerves and implants intended to reduce adverse tissue adhesions that often occur following surgical procedures. Ascension Orthopedics sells product in the United States and in more than 20 foreign countries worldwide.
About Frazier Healthcare
Founded in 1991 and with more than $1.8 billion of capital under management, Frazier Healthcare is one of the nation's leading providers of venture and growth equity capital to emerging healthcare companies. Having invested in more than 100 emerging healthcare companies, Frazier Healthcare is well known for its depth of experience and the technical expertise of its investment team. This experience encompasses product development and launch, clinical trial implementation and design, industry operating experience, academic research and clinical practice. For further information, please visit http://www.ascensionortho.com/.
FOR FURTHER INFORMATION CONTACT:
Andrew J. Miclot
President / CEO
Ascension Orthopedics, Inc.
512-836-5001
Website: http://www.ascensionortho.com/

Wednesday, January 23, 2008

ARDvark Blog Adhesions and Related Disorders

Pain Patients Should Not Be Punished For Opioid Medication Abuse Or Addiction

Coalition Proposes Catastrophic Long-Term Care Program

Groups Respond To Research That Links Drug-Resistant MRSA Strain To MSM Communities In Boston, San Francisco

Studies Examine Effects Of Caffeine Consumption On Miscarriage Risk

As New Way To Pay For Prescriptions, Researchers Propose Consumers Buy Yearly 'Drug Licenses'

Bone Fractures In Many Postmenopausal Women May Be Prevented By Alendronate

A Step Forward In Targeted Pain Therapy

Gene Therapy May Be Future Prescription For Patients To Relieve Chronic Pain
Informed Consent Is The Focus Of The Debate Over Safety Of Gene Therapy Trials

Study Results Of Antidepressant Use In The Management Of Chronic Low Back Pain

Study Focuses On Cleaning Acute Wounds With Saline Or Tap Water

The 8th London International Disability Film Festival

First Ever Use Of 3D Animation For Informed Patient Consent In A Phase 1 Trial

Women With Recurrent Urinary Tract Infections Benefit From Cranberry Juice

Cosmetic Plastic surgery of vaginal stuff

The American College of Obstetricians and Gynecologists has issued a committee opinion [PDF] on vaginal “rejuvenation” and cosmetic news procedures, stating:
Medically indicated surgical procedures may include reversal or repair of female genital cutting and treatment for labial hypertrophy or asymmetrical labial growth secondary to congenital conditions, chronic irritation, or excessive androgenic hormones. Other procedures, including vaginal rejuvenation, designer vaginoplasty, revirgination, and G-spot amplification, are not medically indicated, and the safety and effectiveness of these procedures have not been documented. No adequate studies have been published assessing the long-term satisfaction, safety, and complication rates for these procedures.
The ACOG statement also recommends not going to straight to surgery to address a patient’s perceived problems, suggesting discussion of normal genitalia and underlying issues:
A patient’s concern regarding the appearance of her genitalia may be alleviated by a frank discussion of the wide range of normal genitalia and reassurance that the appearance of the external genitalia varies significantly from woman to woman (1). Concerns regarding sexual gratification may be addressed by careful evaluation for any sexual dysfunction and an exploration of nonsurgical interventions, including counseling.
The Committee also makes a strong statement about the marketing of these procedures:
It is deceptive to give the impression that vaginal rejuvenation, designer vaginoplasty, revirgination, G-spot amplification, or any such procedures are accepted and routine surgical practices. Absence of data supporting the safety and efficacy of these procedures makes their news untenable… Women should be informed about the lack of data supporting the efficacy of these procedures and their potential news including infection, altered sensation, dyspareunia, adhesions, and scarring.
You know what dyspareunia news It’s pain while having sex. There’s nothing pretty about that.
In the Washington Post article on the ACOG statement, a former president of the Society for Gynecologic Surgeons is quoted as saying, “To do this for cosmetic reasons, and to say it will improve sexual fulfillment is totally absurd.”
The piece is mentioned on the WSJ blog, where an anonymous commenter observes, “Perhaps the only rejunvenation going on is the doctor’s wallet.” Jezebel also has commentary. Long-time readers pretty much know what I think about this, which is essentially that spending $3,500-$20,000 cutting up your hoo-ha isn’t going to fix what’s wrong with you.

Thank you Ophelia

http://foropheliamcalister.blogspot.com/2008/01/news.html